The Claim
In critically ill ICU patients with acute kidney injury and metabolic acidosis, sodium bicarbonate therapy reduces the need for renal replacement therapy by 28% (risk ratio 0.72, 95% CI 0.63–0.84) and does not improve 28-day or 90-day survival.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In critically ill ICU patients with acute kidney injury and metabolic acidosis, sodium bicarbonate therapy reduces the need for dialysis by 28% but does not increase survival at 28 or 90 days.
See the scientific wording
In critically ill ICU patients with acute kidney injury and metabolic acidosis, sodium bicarbonate therapy likely reduces the need for renal replacement therapy by 28% (risk ratio 0.72, 95% CI 0.63–0.84) without improving 28-day or 90-day survival, suggesting its benefit may stem from delaying dialysis initiation rather than altering underlying kidney pathology.
When too much acid builds up in the blood, blood vessels in the kidneys tighten and the kidneys filter less waste. Giving sodium bicarbonate raises the blood's pH, which relaxes those blood vessels, lets more blood flow through the kidneys, and helps the kidneys clear out acid and toxins. This reduces the buildup of waste that would otherwise force doctors to start dialysis.
What the research says
1 studyFor very sick kidney patients with too much acid in their blood, giving baking soda (sodium bicarbonate) helps delay the need for dialysis by about 28%, but it doesn’t help them live longer. It’s like buying time, not fixing the kidney.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.